A study conducted by a consortium of Brazilian researchers has
Read more
Home ยป
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
Read more
The phase 1/2 trial of the REGEN-COV (casirivimab and imdevimab)
Read more
The importance of cross-neutralizing antibodies to the recently emerged variants
Read more
As many countries are being hit hard by repeated waves
Read more
A recent study has examined the response of nursing home
Read more
A Korea-based company EyeGene Inc. has recently developed a liposome-based
Read more
As vaccines against the severe acute respiratory syndrome coronavirus 2
Read more
Evotec, a drug company headquartered in Hamburg, Germany, has begun
Read more
Scientists believe that an unbiased analysis of antibody binding sites
Read more